Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ddg.13716_g | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biologika-Therapie mit Anti-IL-17A-Antikörper verbessert kongenitale ichthyosiforme Verhornungsstörung.
J Dtsch Dermatol Ges
January 2019
Klinik für Dermatologie und Venerologie, Universitätsklinikum Freiburg.
[Infectious complications of biologic therapy in patients with rheumatoid arthritis].
Z Rheumatol
December 2010
Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, Hannover, Germany.
The introduction of biological disease-modifying drugs (DMARDs) has substantially improved the treatment options for patients with rheumatoid arthritis. However, infectious complications represent the most common side effects of these drugs, including severe infections as well as rare opportunistic infections. Treating patients on biological DMARDs is therefore one of the biggest challenges in rheumatology care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!